Fate Therapeutics Inc FATE:NASDAQ

Last Price$18.97NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/24/19
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$18.40 (1)
Ask (Size)$19.36 (1)
Day Low / HighN/A - N/A
Volume625.9 K

Analyst Actions: Wedbush Lifts Fate Therapeutics PT to $21 From $19; Maintains Outperform Rating

12:42PM ET 2/11/2019 MT Newswires
Wedbush said Monday it has raised Fate Therapeutics (FATE) price target to $21 from $19, while reiterating its outperform rating.

According to the broker, it is adjusting its price target as it starts to assign value to the company' induced pluripotent stem cell (iPSC)-derived natural killer (NK) cell therapy platform, or '500 series' of cell products. The broker said INDs have now cleared for FT500 and FT516, marking the first induced pluripotent stem cell (iPSC)-derived cell product and first engineered iPSC-derived product, respectively, to reach the clinic.

Price: 15.33, Change: +1.26, Percent Change: +8.93